[ad_1]
An Australian cancer trial using precision radiotherapy to help men with advanced prostate cancer has yielded promising results.
The trial, the largest in the world, treated by stereotactic radiotherapy of the body nearly 200 men with advanced prostate cancer that had spread to other parts of their body.
"This new Australian data gives hope to men with metastatic prostate cancer," said Dr. Icon Bowden, a specialist in radiation oncology in Melbourne.
The treatment uses high doses of radiation to target small areas of cancer while sparing healthy tissue.
Up to 50% of patients were unresponsive to treatment escalation for two years and no patient had serious long-term side effects, according to results published in the US. International Journal of Cancer.
"Unfortunately, it is an incurable disease with a life expectancy of about five years.It is extremely promising to see precision radiotherapy delaying the progression of treatment for more than two years." , did he declare.
The results showed that precision radiotherapy in the treatment of cancer can improve quality, duration and life, said the doctor.
Each year, up to 18,000 men are diagnosed with prostate cancer and 15,000 men currently live with metastatic prostate cancer.
The study was led by experts from the Icon Cancer Center and funded by the Epworth Medical Foundation and EJ Whitten Foundaiton.
[ad_2]
Source link
